GANX
Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)
GANX Filings
Filing Date
Form Description
Form Type
2026-03-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-26
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-26 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-26
Form 8-K - Current report
Key Events
2026-03-26 · Key Events
Form 8-K - Current report
2026-03-18
Form 8-K - Current report
Key Events
2026-03-18 · Key Events
Form 8-K - Current report
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2025-12-18
Form 8-K - Current report
Key Events
2025-12-18 · Key Events
Form 8-K - Current report
2025-12-03
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2025-12-03 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2025-11-28
Form 8-K - Current report
Key Events
2025-11-28 · Key Events
Form 8-K - Current report
2025-11-28
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-28 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
